Article metrics

Download PDFPDF

861 Development of FPA157, an anti-CCR8 depleting antibody engineered to preferentially eliminate tumor-infiltrating T regulatory cells

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020187042
Dec 20204405
Jan 202172012
Feb 20216608
Mar 202180016
Apr 202168021
May 202139023
Jun 20210032
Jul 20210018
Aug 20210021
Sep 20210031
Oct 2021171046
Nov 2021138050
Dec 2021140046
Jan 2022136031
Feb 2022124023
Mar 202282027
Apr 202292029
May 202288014
Jun 202280014
Jul 2022140025
Aug 2022110017
Sep 202278014
Oct 202256011
Nov 20227009
Dec 20223406
Jan 202374029
Feb 202368013
Mar 20234803
Apr 202366015
May 20234203
Jun 20235008
Jul 20234408
Aug 202348014
Sep 20233809
Oct 20232204
Nov 202348010
Dec 20235405
Jan 20247005
Feb 20243402
Mar 20244808
Apr 20245207
May 20243603
Jun 202488010
Jul 20248004
Aug 20242600
Sep 20243202
Oct 202486016
Nov 202498014
Dec 2024102013
Jan 20255608
Feb 20252004
Mar 2025007
Apr 20250012
May 2025008
Jun 2025006
Total35250841